Enclomiphene is a selective estrogen receptor modulator (SERM) that raises a man's own testosterone by blocking estrogen feedback at the brain. Unlike injected testosterone, it keeps LH, FSH, and sperm production intact. It's a daily oral, typically dosed 12.5–25 mg, and is used by men with secondary hypogonadism who want to preserve fertility.
That last part is the whole reason it exists. If you're researching this drug, you probably already know the trade-offs of TRT and want to know whether there's a path that doesn't involve permanently outsourcing your testes. There is — sometimes. This guide covers exactly when enclomiphene is the right call, when it isn't, what real protocols look like, and what to expect month by month.
What Is Enclomiphene and How Does It Actually Work?
Enclomiphene is the trans-isomer of clomiphene citrate, a SERM that blocks estrogen receptors in the hypothalamus. When the brain stops "seeing" estrogen, it ramps up gonadotropin-releasing hormone (GnRH), which raises luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH then signals the testes to produce more endogenous testosterone, while FSH supports sperm production.
The mechanism matters. Standard TRT works by adding testosterone from outside, which suppresses your own LH and FSH and shrinks the testes. Enclomiphene works upstream — it makes the system louder, not quieter. In a phase II trial published in Fertility and Sterility, men taking 12.5 mg or 25 mg of enclomiphene daily raised mean total testosterone from below 300 ng/dL into the 500–600 ng/dL range while sperm concentrations held steady or improved.
It's also worth understanding what enclomiphene is not. It is not a steroid. It does not aromatize. It does not bypass your testes. And it is currently prescribed off-label in the United States — there is no FDA-approved enclomiphene-only product for men, and Androxal (the branded version Repros Therapeutics developed) was never approved.
Who Is Enclomiphene Actually For (and Who Should Skip It)?
Enclomiphene works best for men with secondary hypogonadism — meaning the testes still work, but the brain isn't telling them to. If your low testosterone is caused by primary testicular failure (Klinefelter syndrome, prior chemotherapy, traumatic injury, mumps orchitis), enclomiphene won't help, because there's nothing for higher LH to act on.
The ideal candidate looks like this: under 45, total testosterone in the 200–350 ng/dL range, normal or near-normal LH and FSH, normal testicular size on exam, and either active fertility goals or a strong desire to keep that option open. If your baseline LH is already pegged high (>9 IU/L) and your testes are small, enclomiphene is unlikely to move the needle — that's the primary-hypogonadism signature.
Skip enclomiphene if you have a history of vision disorders, are taking other SERMs, have untreated thyroid disease, or have severely elevated baseline estradiol. Men over 50 with longstanding low T sometimes respond, but the response rate drops with age as Leydig cell capacity declines. The decision belongs in a conversation with an endocrinologist or TRT-experienced urologist — not on Reddit.
Did You Know? Roughly 30–40% of men diagnosed with low testosterone have secondary hypogonadism, where the brain — not the testes — is the bottleneck. That's the population enclomiphene was designed for.
Enclomiphene vs TRT: Which One Is Right for You?
Enclomiphene and TRT both raise testosterone, but they take opposite approaches. TRT replaces what your body isn't making; enclomiphene restores what your body should be making. The right choice depends on your age, fertility goals, baseline labs, and how aggressively you want to push the upper end of your range. Here's the side-by-side.
| Factor | Enclomiphene | TRT (Injectable) |
|---|---|---|
| How it works | Restores endogenous T via LH/FSH | Replaces T from outside source |
| Fertility | Preserved or improved | Usually suppressed within 3–6 months |
| Testicular size | Maintained | Atrophy in most men |
| Typical T range achieved | 450–700 ng/dL | 600–1,000+ ng/dL (protocol-dependent) |
| Symptom relief speed | 4–12 weeks | 2–6 weeks |
| Estradiol management | Usually self-regulating | Often requires AI or dose adjustment |
| Daily commitment | Oral, daily | 1–2 injections per week |
| Best for | Younger men, secondary hypogonadism, fertility | Older men, primary hypogonadism, max optimization |
| Reversibility | Stops with dose hold | HPTA recovery takes 6–18 months after stop |
| Cost (US, monthly) | $80–200 (compounded) | $30–60 (generic) to $200+ (telehealth) |
There is no universal winner. A 32-year-old with a T of 280 ng/dL and a wife who wants kids in two years is a textbook enclomiphene case. A 52-year-old with a T of 220 ng/dL, no fertility goals, and severe symptoms is a textbook TRT case. Most decisions live somewhere between those poles, and the TRT dosage chart is a useful next read if you're leaning toward injections.
Enclomiphene Dosage for Men: What Providers Actually Prescribe
The most common starting dose providers prescribe is 12.5 mg daily, taken orally at the same time each day. If labs at six weeks show insufficient response — total testosterone still under 450 ng/dL with bothersome symptoms — the dose is typically titrated to 25 mg daily. Some men do well on every-other-day dosing once stable, which extends supply and softens estradiol effects.
Three real-world dosing patterns show up in clinical practice:
- Standard daily (12.5 mg) — the default starting point. Works for most secondary-hypogonadism candidates. Recheck labs at 6 and 12 weeks.
- Higher daily (25 mg) — for non-responders to 12.5 mg, or men with starting T below 200 ng/dL. Watch estradiol; some men crash mood or libido at this dose.
- Every-other-day (12.5 mg EOD) — used when 12.5 mg daily over-suppresses estradiol or when cost is a constraint. Slightly slower onset but well-tolerated.
What you won't see in good clinical use: doses above 25 mg daily, dosing without baseline labs, or "stacking" with other SERMs (tamoxifen, clomid) outside of post-cycle protocols. Higher doses don't produce proportionally better results — they just produce more side effects. The Wiehle phase II trial found 25 mg daily delivered the best total-T elevation, with diminishing returns beyond that point.
If 12.5 mg isn't moving your numbers after 12 weeks of consistent use, the answer usually isn't more enclomiphene — it's a different mechanism entirely. This is where a lot of men quietly transition to TRT.
Enclomiphene Side Effects: The Real List
Most men tolerate enclomiphene well, but the side effect profile is real and worth taking seriously — especially the visual ones. The most commonly reported issues are headaches, mood changes (irritability or low mood), nausea, hot flashes, and a small subset of men experience visual disturbances. Vision symptoms are the one category you do not push through.
| Side Effect | Frequency | Severity | What to Do |
|---|---|---|---|
| Headache | ~10–15% | Mild–moderate | Hydration; persists → call provider |
| Mood changes / irritability | ~8–12% | Variable | Track in a symptom log; consider EOD dosing |
| Nausea | 5–8% | Mild | Take with food |
| Hot flashes | 3–6% | Mild | Often resolves in 4–6 weeks |
| Decreased libido (paradoxical) | 3–5% | Variable | Check estradiol — may be too low |
| Visual disturbances (blurred vision, floaters, scotoma) | <2% | Potentially serious | Stop and call provider immediately |
| Gynecomastia | Rare | Variable | Check estradiol/T ratio |
The vision warning is the one clinic pages tend to soft-pedal. SERMs as a class have a rare but documented association with visual side effects — most resolve on stopping the drug, but case reports of persistent symptoms exist. If you notice blurry vision, halos around lights, color changes, or any visual field defect, stop the medication and contact your provider that day. Don't wait for your next appointment.
For a broader view of how hormone protocols can produce unexpected symptoms, the side effects of TRT breakdown covers the comparison side of this conversation.
What to Expect on Enclomiphene: A Month-by-Month Timeline
Enclomiphene works on a slower curve than TRT. LH and FSH rise within the first 1–2 weeks, but the testosterone response takes longer because your testes have to ramp up production. Most men see meaningful symptomatic change between weeks 4 and 12. Here's the realistic before-and-after timeline based on clinical data and observed protocols.
Weeks 1–2. LH and FSH start climbing. You probably feel nothing yet. Some men report mild headaches or nausea adjusting to the SERM mechanism. Track sleep and mood — both are early indicators.
Weeks 3–4. Total testosterone has typically risen 100–200 ng/dL above baseline. Morning erections often return first. Energy and motivation begin shifting. This is when the first real symptom changes show up.
Weeks 6–8. First lab recheck window. Total T should be in the 450–650 ng/dL range; LH and FSH elevated above baseline; estradiol usually rises proportionally with T. Strength and gym output start improving. Body composition changes are not yet visible.
Weeks 10–12. Steady state. Symptom relief is roughly stable. Body composition shifts begin (slow fat loss, modest muscle mass gain in men who train). Sperm parameters either preserved or improved over baseline.
Months 4–6. This is where the decision crystallizes: enclomiphene either works for you or it doesn't. Responders feel dialed in at this point, with consistent T in the high-normal range and resolved hypogonadal symptoms. Non-responders often switch to TRT or revisit the underlying diagnosis.
For comparison, the symptom timeline on TRT tends to be 2–4 weeks faster across most categories — that speed difference is one of the main reasons men cross over.
Enclomiphene vs Clomid: Why the Difference Matters
Clomid (clomiphene citrate) is a 50/50 mixture of two isomers: enclomiphene (the trans-isomer, which is the part doing the testosterone-raising work) and zuclomiphene (the cis-isomer, which has long-acting estrogenic effects and a half-life of roughly 30 days). Enclomiphene-only products strip out the zuclomiphene, which is why side effects like mood swings and visual symptoms are reported less often.
The practical implications:
- Onset and washout. Enclomiphene has a half-life of approximately 10 hours; zuclomiphene's is around 30 days. That means clomid effects compound over weeks of dosing while enclomiphene reaches steady state faster and clears faster.
- Mood profile. The zuclomiphene component is the part most associated with the "clomid mood" — anxiety, depressive episodes, emotional volatility. Pure enclomiphene tends to be cleaner.
- Estrogenic activity. Zuclomiphene's residual estrogenic effect can drive gynecomastia or libido changes that look paradoxical given rising testosterone.
- Cost. Clomid is widely available and cheap (often <$30/month). Enclomiphene is compounded and runs $80–200/month.
If your provider offers clomid as a substitute for enclomiphene, it's not a bad option — it's the same mechanism with a noisier side effect profile. Some men do equally well on both; some only tolerate the pure enclomiphene version. The Earl & Cohen review in Expert Review of Endocrinology & Metabolism covers the comparative pharmacology in depth.
Can You Run Enclomiphene Alongside TRT?
Yes — a small but established cohort of men runs low-dose enclomiphene alongside testosterone injections, primarily to preserve fertility and testicular size. The protocol typically pairs a moderate TRT dose (100–140 mg testosterone cypionate weekly) with 12.5 mg enclomiphene daily, sometimes in place of HCG. There's no FDA approval for this combination, and clinical evidence is limited to case series and provider experience.
Why men do this: HCG is the conventional fertility-preservation add-on for TRT, but it's expensive ($150–400/month), requires reconstitution and refrigeration, and access has been inconsistent in the US since the 2020 compounding restrictions. Enclomiphene is oral, shelf-stable, and often cheaper. The trade-off is that the data supporting it as an HCG alternative on TRT is much thinner than the data for HCG itself.
Practical realities of stacking:
- Sperm parameters don't always recover to the same degree as with HCG. If active conception is the goal, HCG remains the better-evidenced choice.
- Estradiol management gets more complex with two pathways pushing it up.
- LH and FSH suppression from TRT may blunt enclomiphene's effect — your brain's "louder" GnRH signal still hits a partially-suppressed pituitary.
If fertility preservation is your driver, the HCG and TRT guide compares both options in the context of ongoing testosterone therapy. For most men, the conversation is enclomiphene or TRT — not both at once.
What Labs Should You Check on Enclomiphene?
A proper enclomiphene protocol involves a baseline panel, a 6-week check, and a 12-week check, then quarterly thereafter once stable. The labs need to capture both whether the drug is working (T, LH, FSH) and whether it's safe to continue (CBC, lipids, vision symptoms self-report). Skipping the labs is the most common reason men either stay on a non-working dose or miss a brewing problem.
Baseline labs (before starting): - Total testosterone (morning, fasted) - Free testosterone (equilibrium dialysis preferred) - Estradiol (sensitive assay, LC-MS/MS) - LH and FSH - SHBG - Prolactin - TSH - Complete blood count (CBC) - Comprehensive metabolic panel (CMP) - Lipid panel - PSA (if over 40)
Week 6 recheck: Total T, free T, estradiol, LH, FSH, SHBG. The question this lab answers: is the dose working?
Week 12 recheck: Same panel as week 6, plus CBC and lipids. The question this lab answers: is the dose still working and is it safe to continue?
Quarterly maintenance: Total T, free T, estradiol, LH, FSH, CBC. Annual: full panel including PSA and lipids.
For a longer view of timing and frequency — including how the schedule shifts if you're stable for a year-plus — the lab cadence is similar to what's covered in how do I know my TRT dose is right, and the same logic applies here. The only enclomiphene-specific add: if you ever notice visual symptoms, get an ophthalmology referral, not just a recheck.
What Happens When You Stop Enclomiphene?
Stopping enclomiphene is generally simpler than stopping TRT, because your HPTA was never suppressed in the first place. Within 1–2 weeks of discontinuation, LH and FSH return toward baseline, and testosterone follows shortly after. There is no PCT (post-cycle therapy) needed and no extended recovery window. The catch: testosterone usually drops back to your pre-treatment level within 4–6 weeks.
That last point is the one men underestimate. Enclomiphene is not a cure for hypogonadism — it's a continuous treatment. If your baseline T was 250 ng/dL before you started, that's roughly where it'll land again after you stop. Some men maintain a small post-treatment lift if the underlying cause was reversible (weight loss, sleep correction, opioid cessation), but for most secondary-hypogonadism cases, the gains revert.
The "how long can I stay on enclomiphene" question doesn't have a definitive evidence-based answer because long-term studies past 24 months are sparse. Reasonable use windows from clinical practice:
- Short-term (3–6 months): Common for men with reversible secondary hypogonadism — opioid-related, weight-loss-related, or sleep-apnea-related. Resolve the root cause, taper off.
- Medium-term (1–2 years): Common for men preserving fertility while planning to conceive within that window.
- Long-term (2+ years): Less data. Some clinicians use it indefinitely as an alternative to TRT; others rotate or switch to TRT after 18–24 months. This is a conversation to have explicitly with your provider, not a default.
If you stop because you're switching to TRT, the what happens when you stop TRT timeline does not apply — the recovery dynamics are completely different. Stopping enclomiphene is a soft landing; stopping TRT is a managed crash.
Why Your Doctor Might Not Prescribe Enclomiphene (and What to Do)
The reason most general practitioners and even some endocrinologists won't prescribe enclomiphene comes down to three factors: it's off-label for male hypogonadism in the US, it's not on standard formularies (so insurance won't cover it), and it requires a relationship with a compounding pharmacy. None of those are clinical reasons — they're logistical ones — but they keep the drug out of routine practice.
What's actually going on:
- Off-label status. Enclomiphene was never FDA-approved for men. Repros Therapeutics' Androxal trials hit primary endpoints but the FDA declined approval in 2015, citing concerns about whether raising T-without-symptom-resolution was clinically meaningful. The drug exists because compounding pharmacies can produce it from clomiphene.
- Insurance and access. Most US insurance plans don't cover compounded enclomiphene. You'll pay cash, typically $80–200 per month.
- Compounding pharmacy relationships. Providers who prescribe enclomiphene have established relationships with specific compounding pharmacies. A primary care physician usually doesn't.
- Familiarity gap. Many endocrinologists trained before enclomiphene became a discussion topic. They know clomid; they may not know the cleaner isomer profile.
What to do if you want enclomiphene and your doctor declines: ask for a referral to a urologist who specializes in male hormonal health, or look at endocrinology practices that explicitly list TRT and fertility preservation as services. Telehealth providers also prescribe enclomiphene routinely. The how to get on TRT guide covers a lot of the same access logic — you may not get the answer from your PCP, and that's not a clinical failure, it's a scope-of-practice reality.
How Much Does Enclomiphene Cost?
Compounded enclomiphene typically costs $80–200 per month in cash through a compounding pharmacy, with telehealth providers like Hims charging closer to $200/month as a bundled service. Generic clomid (the 50/50 isomer mix) runs $15–30/month through standard pharmacies and is sometimes prescribed as a budget alternative. Insurance rarely covers enclomiphene, so plan on paying out of pocket.
Cost breakdown by source:
| Source | Monthly Cost | Notes |
|---|---|---|
| Compounding pharmacy (direct) | $80–150 | Requires established prescriber relationship |
| Telehealth (Hims, etc.) | $150–250 | Bundled with provider visit and labs |
| Specialty endocrinology clinic | $120–200 | Often includes lab review |
| Generic clomid (substitute) | $15–30 | Different side effect profile |
| TRT (generic injectable) | $30–60 | Cheaper, but different mechanism |
| Brand-name TRT (gel, pellet) | $200–500+ | Insurance-dependent |
If cost is a hard constraint, generic clomid at every-other-day dosing is the cheapest path to the same mechanism. Most men start there before paying for the cleaner enclomiphene-only product. If TRT itself is your alternative, generic injectable testosterone cypionate is the cheapest evidence-based path to symptom relief.
How Himcules Helps You Track an Enclomiphene Protocol
Enclomiphene is a daily oral medication that gets evaluated on lab numbers and symptom trends — which means tracking is the difference between "I think it's working" and "here's exactly what changed and when." Himcules logs daily medication adherence (with a one-tap entry), captures symptom scores across mood, libido, energy, and sleep, and stores your full lab history so you can graph total T, free T, LH, FSH, and estradiol against your timeline.
The fit for an enclomiphene protocol is direct. Daily dosing means missed doses matter, and the testosterone injection tracker workflow adapts to oral medications the same way. Six- and twelve-week lab checks are easier to compare when the data is in one place. And if you ever switch to TRT, your full pre-switch baseline is preserved.
You can download Himcules free on iOS to log enclomiphene doses, track symptom trends, and store lab results in one place — without spreadsheets.
Frequently Asked Questions
Q: Is enclomiphene as good as TRT? A: For men with secondary hypogonadism who want to preserve fertility, enclomiphene can be as effective as TRT for symptom relief while maintaining sperm production. For older men or those with primary hypogonadism, TRT is more reliable. The right choice depends on your baseline labs, age, and goals.
Q: What are the side effects of enclomiphene? A: Most common are headaches (10–15%), mood changes (8–12%), nausea, and hot flashes. Visual disturbances occur in under 2% of men but require immediate discontinuation if they appear. Most side effects resolve when the medication is stopped.
Q: How long can I stay on enclomiphene? A: Typical use windows are 3 months to 2 years, with limited long-term data beyond 24 months. Some clinicians use it indefinitely as an alternative to TRT, but this should be an explicit decision with your provider, not a default protocol.
Q: Will enclomiphene build muscle? A: Indirectly, yes — by raising your testosterone into a normal or high-normal range, enclomiphene supports the same muscle-building effects as having naturally higher T. Men who train consistently typically see modest muscle gains over 3–6 months. It is not a steroid and won't produce steroid-level results.
Q: Is enclomiphene a steroid? A: No. Enclomiphene is a SERM (selective estrogen receptor modulator). It works by blocking estrogen feedback at the brain so your body produces more of its own testosterone. Steroids add hormones from outside; enclomiphene tells your body to make more of its own.
Q: What's the difference between enclomiphene and clomid? A: Clomid is a 50/50 mix of enclomiphene (the active isomer for raising testosterone) and zuclomiphene (a long-acting estrogenic isomer associated with mood and visual side effects). Enclomiphene-only products remove the zuclomiphene, generally producing fewer side effects.
Q: Why don't doctors prescribe enclomiphene? A: Enclomiphene is off-label for male hypogonadism in the US, not covered by most insurance, and requires a compounding pharmacy relationship most general practitioners don't have. It's a logistical barrier, not a clinical one. Urologists and TRT-experienced providers prescribe it routinely.
Sources
- Wiehle RD et al. "Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone." Fertility and Sterility, 2014. PubMed
- Kim ED et al. "Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement." BJU International, 2016. PubMed
- Earl JA, Cohen LE. "Enclomiphene citrate: A treatment that maintains fertility in men with secondary hypogonadism." Expert Review of Endocrinology & Metabolism, 2019. PubMed
- Bhasin S et al. "Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline." Journal of Clinical Endocrinology & Metabolism, 2018. Endocrine Society
- Krzastek SC, Smith RP. "An update on the use of clomiphene citrate to treat hypogonadism in men." Translational Andrology and Urology, 2020. PMC
- Hsieh TC, Pastuszak AW, Hwang K, Lipshultz LI. "Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy." Journal of Urology, 2013. PubMed
- World Journal of Men's Health. "Position Statement: The Potential Use of Enclomiphene for the Treatment of Male Hypogonadism." WJMH
- RxList. "Clomid (Clomiphene Citrate) Drug Information: Side Effects, Interactions, Warnings." RxList
This article is for informational purposes only and is not medical advice. Always consult your healthcare provider about your TRT or enclomiphene protocol.